amifostine anhydrous has been researched along with Endomyocardial Fibrosis in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Endomyocardial Fibrosis: A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerma, M | 1 |
| Kruse, JJ | 1 |
| van Loenen, M | 1 |
| Klein, HR | 1 |
| Bart, CI | 1 |
| Zurcher, C | 1 |
| Wondergem, J | 1 |
1 other study available for amifostine anhydrous and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Increased deposition of von Willebrand factor in the rat heart after local ionizing irradiation.
Topics: Amifostine; Animals; Coronary Vessels; Dose-Response Relationship, Radiation; Endocardium; Endomyoca | 2004 |